STAAR Surgical Co
NASDAQ:STAA
STAAR Surgical Co
NASDAQ:STAA
Price:
43.65 USD
0.18%
Market Closed
Updated:
May 15, 2024
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA
67.2
Current
74
Median
12.9
Industry
Lower
than median
Higher
than industry value
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
EV/EBITDA
=67.2
Enterprise Value
/
1.9B
EBITDA
28.3m
All Countries
| Market Cap | EV/EBITDA | ||||
|---|---|---|---|---|---|
| US |
|
STAAR Surgical Co
NASDAQ:STAA
|
2.1B USD | 67.2 | |
| CH |
|
Alcon AG
SIX:ALC
|
39.4B CHF | 19.7 | |
| JP |
|
Hoya Corp
TSE:7741
|
6.8T JPY | 24.7 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
187.5B DKK | 25.4 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
20.9B USD | 24.8 | |
| US |
|
Cooper Companies Inc
NYSE:COO
|
19.1B USD | 23.8 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
12.3T KRW | -105.8 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
58.5B CNY | 31 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
5.4B GBP | 46.9 | |
| US |
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
5.8B USD | 11.7 | |
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.5B USD | 9.9 |
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBITDA
55.5
2-Years Forward
EV/EBITDA
29.4
3-Years Forward
EV/EBITDA
19.7
You don't have any saved screeners yet
